Beverly L Davidson

Years Active: 2021-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie St-Cyr, Daniel D Child, Emilie Giaime, Alicia R Smith, Christine J Pascua, Seung Hahm, Eddine Saiah, Beverly L Davidson
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapy. PloS one 17 (8) (2022)
Caroline Gubser Keller, Youngah Shin, Alex Mas Monteys, Nicole Renaud, Martin Beibel, Natalia Teider, Thomas Peters, Thomas Faller, Sophie St-Cyr, Judith Knehr, Guglielmo Roma, Alejandro Reyes, Marc Hild, Dmitriy Lukashev, Diethilde Theil, Natalie Dales, Jang-Ho Cha, Beth Borowsky, Ricardo Dolmetsch, Beverly L Davidson, Rajeev Sivasankaran
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion. Nature communications 13 (1) (2022)
Megan S Keiser, Paul T Ranum, Carolyn M Yrigollen, Ellie M Carrell, Geary R Smith, Amy L Muehlmatt, Yong Hong Chen, Joel M Stein, Ronald L Wolf, Enrico Radaelli, Timothy J Lucas, Pedro Gonzalez-Alegre, Beverly L Davidson
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain. Nature medicine 27 (11) (2021)
Alex Mas Monteys, Amiel A Hundley, Paul T Ranum, Luis Tecedor, Amy Muehlmatt, Euyn Lim, Dmitriy Lukashev, Rajeev Sivasankaran, Beverly L Davidson
Regulated control of gene therapies by drug-induced splicing. Nature 596 (7871) (2021)

Beverly L Davidson.css-eqlu8i{font-size:small;padding-left:4px;}